Literature DB >> 24374819

Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients.

Dayana Bravo1, Carlos Solano, Estela Giménez, María José Remigia, Isabel Corrales, Paula Amat, David Navarro.   

Abstract

The current study was aimed at investigating whether the single nucleotide polymorphism (SNP) (rs12979860), upstream of the IL28B gene, had any effect on the incidence rate and the features of active CMV infection in the Allogeneic stem cell transplantation setting. This was a retrospective observational study including 151 patients undergoing T cell-replete Allo-SCT. Donor and recipient IL28 SNP genotype was determined by allele-specific real-time PCR. The incidence rate of active CMV infection was not significantly associated with either the donor or the recipient IL28B SNP genotype. Nevertheless, a trend towards a lower incidence of active CMV infection was noted in the donor T/T population with respect to the donor C/T and C/C population. The duration of first episodes of CMV DNAemia was significantly shorter in patients carrying the donor T/T genotype with respect to their C/C or C/T counterparts (P = 0.038). Peak CMV DNAmeia levels tended to be lower in patients carrying the T/T genotype (donor or recipient) than in C/C or C/T patients, although statistical significance was not reached. In conclusion the data presented pointed to a protective effect of the T allele (recessive genetic model) against CMV infection in the Allo-SCT setting.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  CMV DNAemia; IL28B; allogeneic stem cell transplantation; cytomegalovirus

Mesh:

Substances:

Year:  2013        PMID: 24374819     DOI: 10.1002/jmv.23865

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  20 in total

Review 1.  The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.

Authors:  Miriam Ciáurriz; Amaya Zabalza; Lorea Beloki; Cristina Mansilla; Estela Pérez-Valderrama; Mercedes Lachén; Eva Bandrés; Eduardo Olavarría; Natalia Ramírez
Journal:  Cell Mol Life Sci       Date:  2015-07-15       Impact factor: 9.261

Review 2.  CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Authors:  Emily Blyth; Barbara Withers; Leighton Clancy; David Gottlieb
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

Review 3.  Risk stratification and immunogenetic risk for infections following stem cell transplantation.

Authors:  Agnieszka Wójtowicz; Pierre-Yves Bochud
Journal:  Virulence       Date:  2016-09-09       Impact factor: 5.882

4.  Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients.

Authors:  Loralie J Langman; Lior Nesher; Dimpy P Shah; Jacques M Azzi; Elizabeth J Shpall; Katy Rezvani; John L Black; Roy F Chemaly
Journal:  J Mol Diagn       Date:  2016-06-29       Impact factor: 5.568

Review 5.  Herpesviruses and the Type III Interferon System.

Authors:  Yue Yin; Herman W Favoreel
Journal:  Virol Sin       Date:  2021-01-05       Impact factor: 4.327

Review 6.  The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; D Lorne Tyrrell; Michael Houghton
Journal:  Emerg Microbes Infect       Date:  2014-07-16       Impact factor: 7.163

7.  IL-28B is a key regulator of B- and T-cell vaccine responses against influenza.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; Khaled Barakat; Mohammedyaseen Syedbasha; Madeleine Vollmer; Aliyah Baluch; Rakesh Bhat; Jody Groenendyk; Michael A Joyce; Luiz F Lisboa; Brad S Thomas; Manuel Battegay; Nina Khanna; Thomas Mueller; D Lorne J Tyrrell; Michael Houghton; Atul Humar; Deepali Kumar
Journal:  PLoS Pathog       Date:  2014-12-11       Impact factor: 6.823

Review 8.  Interferon Lambda: Modulating Immunity in Infectious Diseases.

Authors:  Mohammedyaseen Syedbasha; Adrian Egli
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

9.  Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.

Authors:  Shahinaz M Gadalla; Youjin Wang; Tao Wang; Olusegun O Onabajo; A Rouf Banday; Adeola Obajemu; Ezgi Karaesman; Lara Sucheston-Campbell; Theresa Hahn; Jennifer A Sees; Stephen R Spellman; Stephanie J Lee; Hormuzd A Katki; Ludmila Prokunina-Olsson
Journal:  Lancet Haematol       Date:  2020-10       Impact factor: 18.959

10.  Genetic variants associated with cytomegalovirus infection after allogeneic hematopoietic cell transplantation.

Authors:  Amanda M Casto; Sachiko Seo; David M Levine; Barry E Storer; Xinyuan Dong; John A Hansen; Michael Boeckh; Paul J Martin
Journal:  Blood       Date:  2021-10-28       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.